{
  "page": 8,
  "value": [
    {
      "path": "_news/2020-03-25-brief-gilead-requests-fda-pull-orphan-drug-designation-from-potential-coronavirus-drug.md",
      "title": "BRIEF-Gilead requests FDA pull orphan drug designation from potential coronavirus drug",
      "excerpt": "Gilead Sciences Inc: * Says requested the U.S. FDA rescind the orphan drug designation it was granted for potential coronavirus drug remdesivir * Says waiving all benefits that accompany orphan drug designation for remdesivir * Says confident that it can maintain an expedited timeline in seeking regulatory review of remdesivir Further company coverage: (Reporting By Michael Erman) Our Standards:The Thomson Reuters Trust Principles.",
      "heat": 107,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/brief-gilead-requests-fda-pull-orphan-dr-idUSL1N2BI1PA",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL1N2BI1PA",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL1N2BI1PA",
      "publishedDateTime": "2020-03-25T10:48:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "BRIEF-Gilead requests FDA pull orphan drug designation from potential coronavirus drug",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-covid-19-research-uc-san-diego-begins-testing-experimental-drug-for-fighting-coronavirus.md",
      "title": "COVID-19 research: UC San Diego begins testing experimental drug for fighting coronavirus",
      "excerpt": "UC San Diego said Tuesday that it is beginning to test whether remdesivir, an experimental antiviral drug, can be safely and effectively used to fight the novel coronavirus . The school is joining with University of California medical centers at Irvine,",
      "heat": 111,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.sandiegouniontribune.com/news/science/story/2020-03-24/covid-19-health-ucsd-drug-trial",
      "ampWebUrl": "https://www.sandiegouniontribune.com/news/science/story/2020-03-24/covid-19-health-ucsd-drug-trial?_amp=true",
      "cdnAmpWebUrl": "https://www-sandiegouniontribune-com.cdn.ampproject.org/c/s/www.sandiegouniontribune.com/news/science/story/2020-03-24/covid-19-health-ucsd-drug-trial?_amp=true",
      "publishedDateTime": "2020-03-25T08:50:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "San Diego Union-Tribune",
        "domain": "sandiegouniontribune.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://ca-times.brightspotcdn.com/dims4/default/3de7005/2147483647/strip/true/crop/3024x1975+0+146/resize/320x209!/quality/90/?url=https%3A%2F%2Fcalifornia-times-brightspot.s3.amazonaws.com%2Fb6%2F73%2Fcfca9b914994bd002b870005233e%2Fwd.jpg",
          "width": 320,
          "height": 209,
          "title": "COVID-19 research: UC San Diego begins testing experimental drug for fighting coronavirus",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-biotech-stock-roundup-hoth-imv-to-develop-coronavirus-vaccines-more.md",
      "title": "Biotech Stock Roundup: HOTH & IMV to Develop Coronavirus Vaccines, & More",
      "excerpt": "While the prime focus is currently on coronavirus treatments and vaccines for the biotech sector, a few other updates were also out this week. A slew of biotechs is evaluating their pipeline drugs and vaccines for the treatment of COVID-19 and updates from these companies will drive their share prices.",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-hoth-imv-to-develop-coronavirus-vaccines-more-2020-03-25",
      "ampWebUrl": "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-hoth-imv-to-develop-coronavirus-vaccines-more-2020-03-25?amp",
      "cdnAmpWebUrl": "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/biotech-stock-roundup%3A-hoth-imv-to-develop-coronavirus-vaccines-more-2020-03-25?amp",
      "publishedDateTime": "2020-03-25T08:34:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Nasdaq",
        "domain": "nasdaq.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1060988835",
          "width": 1024,
          "height": 512,
          "title": "Biotech Stock Roundup: HOTH & IMV to Develop Coronavirus Vaccines, & More",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-5-stocks-to-buy-in-the-coronavirus-bear-market.md",
      "title": "5 Stocks to Buy in the Coronavirus Bear Market",
      "excerpt": "More and more Americans are being laid off, working remotely, or just staying at home because of COVID-19, meaning the coronavirus is poised to create a major shift in the way companies do business. While some industries,",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nasdaq.com/articles/5-stocks-to-buy-in-the-coronavirus-bear-market-2020-03-25",
      "ampWebUrl": "https://www.nasdaq.com/articles/5-stocks-to-buy-in-the-coronavirus-bear-market-2020-03-25?amp",
      "cdnAmpWebUrl": "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/5-stocks-to-buy-in-the-coronavirus-bear-market-2020-03-25?amp",
      "publishedDateTime": "2020-03-25T08:33:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Nasdaq",
        "domain": "nasdaq.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?545881188",
          "width": 1024,
          "height": 512,
          "title": "5 Stocks to Buy in the Coronavirus Bear Market",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-duke-university-hospital-will-help-test-potential-treatment-for-covid-19.md",
      "title": "Duke University Hospital will help test potential treatment for COVID-19",
      "excerpt": "Currently, there are no approved therapies for this disease, so we are eager to contribute in any way to help find ways to fight this global pandemic.”",
      "heat": 114,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.newsobserver.com/news/coronavirus/article241491106.html",
      "ampWebUrl": "https://amp.newsobserver.com/news/coronavirus/article241491106.html",
      "cdnAmpWebUrl": "https://amp-newsobserver-com.cdn.ampproject.org/c/s/amp.newsobserver.com/news/coronavirus/article241491106.html",
      "publishedDateTime": "2020-03-25T05:45:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Raleigh News & Observer",
        "domain": "newsobserver.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/5502557045001/ba4a3725-4858-4f88-8e04-2e3a347addfa/1c840ef2-2aff-4231-b425-90b75a81bdea/1280x720/match/image.jpg",
          "width": 1280,
          "height": 720,
          "title": "Duke University Hospital will help test potential treatment for COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-justice-dept-warns-hoarders-of-masks-and-drugs-that-trump-has-touted-as-coronavirus-treatment.md",
      "title": "Justice Dept. warns hoarders of masks and drugs that Trump has touted as coronavirus treatment",
      "excerpt": "You will be hearing a knock on your door,” Attorney General William P. Barr warned those stockpiling supplies.",
      "heat": 108,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/national/coronavirus-masks-medication-hoarding/2020/03/24/782349a8-6df0-11ea-aa80-c2470c6b2034_story.html",
      "ampWebUrl": "https://www.washingtonpost.com/national/coronavirus-masks-medication-hoarding/2020/03/24/782349a8-6df0-11ea-aa80-c2470c6b2034_story.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/national/coronavirus-masks-medication-hoarding/2020/03/24/782349a8-6df0-11ea-aa80-c2470c6b2034_story.html?outputType=amp",
      "publishedDateTime": "2020-03-25T03:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/gks2DZ8zQNbgJwuiAOwVXKuO5CE=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/BYZIRTDOBMI6VKUAYJDQY2ZAGQ.jpg",
          "width": 1440,
          "height": 960,
          "title": "Justice Dept. warns hoarders of masks and drugs that Trump has touted as coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-coronavirus-vaccine-when-will-it-be-ready.md",
      "title": "Coronavirus vaccine: when will it be ready?",
      "excerpt": "Human trials will begin imminently – but even if they go well and a cure is found, there are many barriers before global immunisation is feasible",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.theguardian.com/world/2020/mar/25/coronavirus-vaccine-when-will-it-be-ready-trials-cure-immunisation",
      "ampWebUrl": "https://amp.theguardian.com/world/2020/mar/25/coronavirus-vaccine-when-will-it-be-ready-trials-cure-immunisation",
      "cdnAmpWebUrl": "https://amp-theguardian-com.cdn.ampproject.org/c/s/amp.theguardian.com/world/2020/mar/25/coronavirus-vaccine-when-will-it-be-ready-trials-cure-immunisation",
      "publishedDateTime": "2020-03-25T02:49:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Guardian",
        "domain": "theguardian.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/theguardian.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://i.guim.co.uk/img/media/f1a723c4431b974f8b6ad4f7a34e0ada9e169b51/0_0_2560_1536/master/2560.jpg?width=300&quality=45&auto=format&fit=max&dpr=2&s=826f8c93416494b440ed77c48630dbe9",
          "width": 600,
          "height": 360,
          "title": "Coronavirus vaccine: when will it be ready?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-dont-listen-to-twitter-there-is-no-safe-coronavirus-treatment-yet.md",
      "title": "Don’t Listen to Twitter. There Is No Safe Coronavirus Treatment (Yet).",
      "excerpt": "We would love to be able to say we have a treatment for Covid-19. It is nice to think about a cure, especially when things seem to get worse every day. But we implore you to follow medical professionals’ advice and not get or take an experimental medication recommended without evidence of its success.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/03/25/opinion/coronavirus-drug-treatment-trump.html",
      "ampWebUrl": "https://www.nytimes.com/2020/03/25/opinion/coronavirus-drug-treatment-trump.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/03/25/opinion/coronavirus-drug-treatment-trump.amp.html",
      "publishedDateTime": "2020-03-25T02:13:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/images/2020/03/25/opinion/25Turban/25Turban-facebookJumbo.jpg",
          "width": 1050,
          "height": 550,
          "title": "Don’t Listen to Twitter. There Is No Safe Coronavirus Treatment (Yet).",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-potential-coronavirus-treatment-granted-rare-disease-status.md",
      "title": "Potential coronavirus treatment granted rare disease status",
      "excerpt": "Potential coronavirus treatment granted rare disease status What that specialty status will actually mean for the marketing or profitability of the Gilead Science’s experimental drug remdesivir isn’t clear Check out this story on detroitnews.com: https://www.detroitnews.com/story/news/nation/2020/03/24/potential-coronavirus-treatment ...",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.detroitnews.com/story/news/nation/2020/03/24/potential-coronavirus-treatment-granted-rare-disease-status/111462138/",
      "ampWebUrl": "https://amp.detroitnews.com/amp/111462138",
      "cdnAmpWebUrl": "https://amp-detroitnews-com.cdn.ampproject.org/c/s/amp.detroitnews.com/amp/111462138",
      "publishedDateTime": "2020-03-24T17:44:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Detroit News",
        "domain": "detroitnews.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.gannett-cdn.com/presto/2020/03/25/PDTN/028cd9e4-8981-40a8-8670-bba9077aed24-AP20084538036165.jpg?auto=webp&crop=2345,1320,x0,y103&format=pjpg&width=1200",
          "width": 1200,
          "height": 675,
          "title": "Potential coronavirus treatment granted rare disease status",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-fda-approves-plasma-treatment-for-coronavirus-on-conditional-basis.md",
      "title": "FDA Approves Plasma Treatment for Coronavirus on Conditional Basis",
      "excerpt": "The blood plasma of patients who have recovered from Covid-19 will be allowed for conditional use in treating the disease even though the effectiveness is unproven.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.wsj.com/articles/fda-approves-plasma-treatment-for-coronavirus-under-certain-circumstances-11585090669",
      "ampWebUrl": "https://www.wsj.com/amp/articles/fda-approves-plasma-treatment-for-coronavirus-under-certain-circumstances-11585090669",
      "cdnAmpWebUrl": "https://www-wsj-com.cdn.ampproject.org/c/s/www.wsj.com/amp/articles/fda-approves-plasma-treatment-for-coronavirus-under-certain-circumstances-11585090669",
      "publishedDateTime": "2020-03-24T16:08:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Wall Street Journal",
        "domain": "wsj.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/wsj.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://images.wsj.net/im-168704/social",
          "width": 1280,
          "height": 640,
          "title": "FDA Approves Plasma Treatment for Coronavirus on Conditional Basis",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-potential-coronavirus-treatment-granted-rare-disease-status.md",
      "title": "Potential coronavirus treatment granted rare disease status",
      "excerpt": "Congressional and White House officials said Tuesday a deal appears to be at hand to provide sweeping aid to businesses and workers facing ruin from the",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://abcnews.go.com/Health/wireStory/potential-coronavirus-treatment-granted-rare-disease-status-69776921",
      "ampWebUrl": "https://abcnews.go.com/amp/Health/wireStory/potential-coronavirus-treatment-granted-rare-disease-status-69776921",
      "cdnAmpWebUrl": "https://abcnews-go-com.cdn.ampproject.org/c/s/abcnews.go.com/amp/Health/wireStory/potential-coronavirus-treatment-granted-rare-disease-status-69776921",
      "publishedDateTime": "2020-03-24T13:06:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "ABC",
        "domain": "go.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s.abcnews.com/images/Health/WireAP_b332c7a0b4d6429590db951e132d5e9b_16x9_992.jpg",
          "width": 992,
          "height": 558,
          "title": "Potential coronavirus treatment granted rare disease status",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-hospitals-to-test-whether-blood-from-coronavirus-survivors-can-treat-the-newly-ill.md",
      "title": "Hospitals to test whether blood from coronavirus survivors can treat the newly ill",
      "excerpt": "WASHINGTON — Hospitals are gearing up to test if a century-old treatment used to fight ... it doesn't harbor any blood-borne viruses and is safe to use. For COVID-19 research, the difference would be who does the donating — people who have recovered from the coronavirus. Scientists would measure how many antibodies are in a unit of donated ...",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.inquirer.com/health/coronavirus/coronavirus-covid-19-treatment-hospitals-tests-blood-survivors-20200324.html",
      "ampWebUrl": "https://www.inquirer.com/health/coronavirus/coronavirus-covid-19-treatment-hospitals-tests-blood-survivors-20200324.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-inquirer-com.cdn.ampproject.org/c/s/www.inquirer.com/health/coronavirus/coronavirus-covid-19-treatment-hospitals-tests-blood-survivors-20200324.html?outputType=amp",
      "publishedDateTime": "2020-03-24T09:22:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Philadelphia Inquirer",
        "domain": "inquirer.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.inquirer.com/resizer/YZFDOfWkc6LR2ZjTHBqJAUJDqU8=/1200x0/center/middle/www.inquirer.com/resizer/_RK_MVJWnbfN4TzsECxg6sGP0Cw=/1200x0/center/middle/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/AQ6R4I5KCRERJEXI6GLQXD5YPA.jpg",
          "width": 1200,
          "height": 800,
          "title": "Hospitals to test whether blood from coronavirus survivors can treat the newly ill",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-coronavirus-live-updates-new-cases-surge-in-spain-dow-futures-jump.md",
      "title": "Coronavirus live updates: New cases surge in Spain; Dow futures jump",
      "excerpt": "As of Tuesday, more than 387,382 cases of coronavirus have been reported, resulting in at least 16,767 deaths.",
      "heat": 100,
      "tags": [
        "Spain",
        "ES",
        "Italy",
        "IT"
      ],
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/03/24/coronavirus-live-updates.html",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-03-24T05:04:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": null,
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Stock Impact",
        "Coronavirus",
        "Coronavirus in Europe",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-24-gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.md",
      "title": "Gilead's potential coronavirus treatment gets FDA's orphan drug label",
      "excerpt": "Gilead Sciences' experimental drug remdesivir, seen as one of the more promising potential treatments for the coronavirus, on Monday received the orphan drug designation from the U.S. Food and Drug Administration. Remdesivir is seen as one of the more promising potential treatments for the coronavirus. The orphan drug status provides a seven ...",
      "heat": 150,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/03/24/gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/03/24/gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/03/24/gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.html",
      "publishedDateTime": "2020-03-24T02:42:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/105733600-1549973302033rts1phdi.jpg?v=1549973374",
          "width": 5299,
          "height": 3533,
          "title": "Gilead's potential coronavirus treatment gets FDA's orphan drug label",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-coronavirus-treatment-arizona-man-dies-after-ingesting-chloroquine-the-drug-trump-touted.md",
      "title": "Coronavirus Treatment: Arizona Man Dies After Ingesting Chloroquine, The Drug Trump Touted",
      "excerpt": "President Donald Trump has recently described, falsely, that chloroquine as well as another drug were \"game changers\" in the fight against COVID-19.",
      "heat": 101,
      "tags": [
        "US"
      ],
      "type": "article",
      "webUrl": "https://www.ibtimes.com/coronavirus-treatment-arizona-man-dies-after-ingesting-chloroquine-drug-trump-touted-2945153",
      "ampWebUrl": "https://www.ibtimes.com/coronavirus-treatment-arizona-man-dies-after-ingesting-chloroquine-drug-trump-touted-2945153?amp=1",
      "cdnAmpWebUrl": "https://www-ibtimes-com.cdn.ampproject.org/c/s/www.ibtimes.com/coronavirus-treatment-arizona-man-dies-after-ingesting-chloroquine-drug-trump-touted-2945153?amp=1",
      "publishedDateTime": "2020-03-23T20:53:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "International Business Times",
        "domain": "ibtimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2020/03/19/coronavirus-drug-clinical-trial.jpg",
          "width": 1200,
          "height": 801,
          "title": "Coronavirus Treatment: Arizona Man Dies After Ingesting Chloroquine, The Drug Trump Touted",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in US"
      ]
    },
    {
      "path": "_news/2020-03-24-the-coronavirus-is-hitting-us-prisons-and-advocates-fear-sick-inmates-will-be-afraid-to-get-treatment.md",
      "title": "The Coronavirus Is Hitting US Prisons, And Advocates Fear Sick Inmates Will Be Afraid To Get Treatment",
      "excerpt": "\"It's an existing public health nightmare, and then you add a pandemic that requires social distance and sanitation — it's a powder keg,\" an inmate advocate said. The journalists at BuzzFeed News are proud to bring you trustworthy and relevant reporting about the coronavirus.",
      "heat": 104,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.buzzfeednews.com/article/salvadorhernandez/coronavirus-us-prisons-outbreak",
      "ampWebUrl": "https://www.buzzfeednews.com/amphtml/salvadorhernandez/coronavirus-us-prisons-outbreak",
      "cdnAmpWebUrl": "https://www-buzzfeednews-com.cdn.ampproject.org/c/s/www.buzzfeednews.com/amphtml/salvadorhernandez/coronavirus-us-prisons-outbreak",
      "publishedDateTime": "2020-03-23T17:37:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "BuzzFeed News",
        "domain": "buzzfeednews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/buzzfeednews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://img.buzzfeed.com/buzzfeed-static/static/2017-03/14/7/campaign_images/buzzfeed-prod-fastlane-02/prison-inspectors-found-inmates-could-only-shower-2-27258-1489491533-0_dblbig.jpg",
          "width": 625,
          "height": 415,
          "title": "The Coronavirus Is Hitting US Prisons, And Advocates Fear Sick Inmates Will Be Afraid To Get Treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-24-an-man-died-after-self-medicating-with-a-drug-trump-promoted-as-a-potential-treatment-for-the-coronavirus.md",
      "title": "An Man Died After Self-Medicating With A Drug Trump Promoted As A Potential Treatment For The Coronavirus",
      "excerpt": "The elderly man died after taking chloroquine phosphate, an additive used to clean fish tanks. Trump has been promoting chloroquine as a potential treatment for the coronavirus, but health officials say it hasn't been tested properly.",
      "heat": 113,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.buzzfeednews.com/article/briannasacks/man-died-chloroquine-phosphate-coronavirus",
      "ampWebUrl": "https://www.buzzfeednews.com/amphtml/briannasacks/man-died-chloroquine-phosphate-coronavirus",
      "cdnAmpWebUrl": "https://www-buzzfeednews-com.cdn.ampproject.org/c/s/www.buzzfeednews.com/amphtml/briannasacks/man-died-chloroquine-phosphate-coronavirus",
      "publishedDateTime": "2020-03-23T17:16:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "BuzzFeed News",
        "domain": "buzzfeednews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/buzzfeednews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://img.buzzfeed.com/buzzfeed-static/static/2020-03/20/16/campaign_images/73e656f20c04/here-are-5-of-the-most-googled-coronavirus-questi-2-2744-1584721920-10_dblbig.jpg",
          "width": 625,
          "height": 415,
          "title": "An Man Died After Self-Medicating With A Drug Trump Promoted As A Potential Treatment For The Coronavirus",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-south-koreas-method-coronavirus-treatment-softbank-your-tuesday-briefing.md",
      "title": "South Korea’s Method, Coronavirus Treatment, SoftBank: Your Tuesday Briefing",
      "excerpt": "Here’s what you need to know. (Want to get this briefing by email? Here’s the sign-up .) Good morning. We’re covering what South Korea did to flatten its curve, hopes for countries struggling to stop their outbreaks and negotiating an Afghan peace deal via Skype.",
      "heat": 152,
      "tags": [
        "KR"
      ],
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/03/23/briefing/south-korea-coronavirus-treatment-olympics.html",
      "ampWebUrl": "https://www.nytimes.com/2020/03/23/briefing/south-korea-coronavirus-treatment-olympics.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/03/23/briefing/south-korea-coronavirus-treatment-olympics.amp.html",
      "publishedDateTime": "2020-03-23T16:13:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/images/2020/03/23/world/23virus-korea03-copy/23virus-korea03-facebookJumbo.jpg",
          "width": 1050,
          "height": 550,
          "title": "South Korea’s Method, Coronavirus Treatment, SoftBank: Your Tuesday Briefing",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in South Korea",
        "Coronavirus in Asia",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-23-gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.md",
      "title": "Gilead's potential coronavirus treatment gets FDA's orphan drug label",
      "excerpt": "Gilead Sciences Inc’s experimental drug remdesivir, seen as one of the more promising potential treatments for the coronavirus, on Monday received the orphan drug designation from the U.S. Food and Drug Administration.",
      "heat": 140,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-gilead-sciences-idUSKBN21A3PR",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN21A3PR",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN21A3PR",
      "publishedDateTime": "2020-03-23T15:03:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources/r/?m=02&d=20200323&t=2&i=1507244053&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG2M25T",
          "width": 817,
          "height": 545,
          "title": "Gilead's potential coronavirus treatment gets FDA's orphan drug label",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-uc-irvine-researchers-to-test-former-ebola-drug-in-coronavirus-clinical-trial.md",
      "title": "UC Irvine researchers to test former Ebola drug in coronavirus clinical trial",
      "excerpt": "Remdesivir was developed by Gilead Sciences, which has shut down its emergency access program for the drug due overwhelming demand.",
      "heat": 102,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.bizjournals.com/losangeles/news/2020/03/23/uc-irvine-researchers-to-test-former-ebola-drug-in.html",
      "ampWebUrl": "https://www.bizjournals.com/losangeles/news/2020/03/23/uc-irvine-researchers-to-test-former-ebola-drug-in.amp.html",
      "cdnAmpWebUrl": "https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/losangeles/news/2020/03/23/uc-irvine-researchers-to-test-former-ebola-drug-in.amp.html",
      "publishedDateTime": "2020-03-23T11:25:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Business Journals",
        "domain": "bizjournals.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://media.bizj.us/view/img/11629053/covid-19-alissa-eckert-ms-dan-higgins-mams*600xx3375-2250-313-0.jpg",
          "width": 600,
          "height": 400,
          "title": "UC Irvine researchers to test former Ebola drug in coronavirus clinical trial",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-protests-at-uk-cinemas-treatment-of-staff-after-coronavirus-shutdown.md",
      "title": "Protests at UK cinemas' treatment of staff after coronavirus shutdown",
      "excerpt": "Staff of major chains have been hit by lack of clarity in the wake of employment terminations and cinema closures",
      "heat": 145,
      "tags": [
        "GB",
        "UK"
      ],
      "type": "article",
      "webUrl": "https://www.theguardian.com/film/2020/mar/23/protests-at-cinema-chains-treatment-of-staff-coronavirus",
      "ampWebUrl": "https://amp.theguardian.com/film/2020/mar/23/protests-at-cinema-chains-treatment-of-staff-coronavirus",
      "cdnAmpWebUrl": "https://amp-theguardian-com.cdn.ampproject.org/c/s/amp.theguardian.com/film/2020/mar/23/protests-at-cinema-chains-treatment-of-staff-coronavirus",
      "publishedDateTime": "2020-03-23T10:36:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Guardian",
        "domain": "theguardian.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/theguardian.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://i.guim.co.uk/img/media/d9ba9369cc2d3b77412d8fa6920c81d70bee5517/1264_476_6682_4009/master/6682.jpg?width=300&quality=45&auto=format&fit=max&dpr=2&s=a67d76ee9d867a4e5eaf461a6518aefd",
          "width": 600,
          "height": 360,
          "title": "Protests at UK cinemas' treatment of staff after coronavirus shutdown",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in Europe",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-23-will-disabled-people-be-at-a-disadvantage-for-scarce-coronavirus-treatment.md",
      "title": "Will Disabled People Be at a Disadvantage for Scarce Coronavirus Treatment?",
      "excerpt": "Advocates in Washington State fear that people who are disabled could be at higher risk of death when doctors and hospitals make end-of-life triage decisions. SEATTLE — Groups representing people with disabilities on Monday challenged a plan that would guide hospitals in Washington State dealing with the coronavirus in the event that they do not have enough lifesaving resources for all the patients who need them.",
      "heat": 118,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/03/23/us/coronavirus-washington-triage-disabled-handicapped.html",
      "ampWebUrl": "https://www.nytimes.com/2020/03/23/us/coronavirus-washington-triage-disabled-handicapped.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/03/23/us/coronavirus-washington-triage-disabled-handicapped.amp.html",
      "publishedDateTime": "2020-03-23T10:20:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/images/2020/03/23/us/23virus-complaint/23virus-complaint-facebookJumbo.jpg",
          "width": 1050,
          "height": 549,
          "title": "Will Disabled People Be at a Disadvantage for Scarce Coronavirus Treatment?",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-gilead-suspends-emergency-access-to-experimental-coronavirus-drug-remdesivir.md",
      "title": "Gilead suspends emergency access to experimental coronavirus drug remdesivir",
      "excerpt": "Biotechnology company Gilead Sciences is halting emergency access to its experimental coronavirus drug, citing \"overwhelming demand.\" The coronavirus outbreak has caused such a surge in requests for the drug,",
      "heat": 112,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cbsnews.com/news/gilead-sciences-coronavirus-drug-remdesivir-overwhelming-demand/",
      "ampWebUrl": "https://www.cbsnews.com/amp/news/gilead-sciences-coronavirus-drug-remdesivir-overwhelming-demand/",
      "cdnAmpWebUrl": "https://www-cbsnews-com.cdn.ampproject.org/c/s/www.cbsnews.com/amp/news/gilead-sciences-coronavirus-drug-remdesivir-overwhelming-demand/",
      "publishedDateTime": "2020-03-23T10:05:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CBS News",
        "domain": "cbsnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cbsnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cbsnews2.cbsistatic.com/hub/i/r/2014/10/10/0b14d763-4bda-48b4-a05f-823f1320dfd0/thumbnail/1200x630/37310a00b7577d3a29990642e23ee089/ap570444828331.jpg",
          "width": 1200,
          "height": 630,
          "title": "Gilead suspends emergency access to experimental coronavirus drug remdesivir",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-cuomo-announces-3-clinical-trials-for-coronavirus-treatment-in-new-york.md",
      "title": "Cuomo announces 3 clinical trials for coronavirus treatment in New York",
      "excerpt": "New York Governor Andrew Cuomo announced that New York state will be starting three clinical trials for coronavirus treatment this week as the number of positive cases continue to rise in the state. March 23,",
      "heat": 110,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nbcnews.com/video/cuomo-announces-3-clinical-trials-for-coronavirus-treatment-in-new-york-81097285838",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-03-23T09:00:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "NBC News",
        "domain": "nbcnews.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://media13.s-nbcnews.com/j/MSNBC/Components/Video/202003/f_mo_cuomo_new_trials_200323_1920x1080.nbcnews-fp-1200-630.jpg",
          "width": 1200,
          "height": 630,
          "title": "Cuomo announces 3 clinical trials for coronavirus treatment in New York",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-trump-says-coronavirus-cure-cannot-be-worse-than-the-problem-itself.md",
      "title": "Trump Says Coronavirus Cure Cannot ‘Be Worse Than the Problem Itself’",
      "excerpt": "The president, who has watched the economy plunge amid social distancing measures, says restrictions will be reassessed. President Trump on Sunday night said that the government would reassess the recommended period for “social distancing” after this week,",
      "heat": 125,
      "tags": [
        "US"
      ],
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/03/23/us/politics/trump-coronavirus-restrictions.html",
      "ampWebUrl": "https://www.nytimes.com/2020/03/23/us/politics/trump-coronavirus-restrictions.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/03/23/us/politics/trump-coronavirus-restrictions.amp.html",
      "publishedDateTime": "2020-03-23T05:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://static01.nyt.com/images/2020/03/23/world/23dc-virus-trump/23dc-virus-trump-facebookJumbo.jpg",
          "width": 1050,
          "height": 550,
          "title": "Trump Says Coronavirus Cure Cannot ‘Be Worse Than the Problem Itself’",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in US"
      ]
    },
    {
      "path": "_news/2020-03-23-rpt-stay-at-home-stocks-rise-from-wall-streets-coronavirus-rubble.md",
      "title": "RPT-Stay at home stocks rise from Wall Street's coronavirus rubble",
      "excerpt": "As coronavirus fears inflict havoc on Wall Street, a few stocks are thriving on expectations that millions of people will spend weeks or longer cooped up at home. Meal-kit delivery company Blue Apron Holdings has been a major gainer from social distancing to avoid COVID-19,",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/usa-stocks-coronavirus-winners-idUSL1N2BD264",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL1N2BD264",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL1N2BD264",
      "publishedDateTime": "2020-03-23T04:10:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "RPT-Stay at home stocks rise from Wall Street's coronavirus rubble",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-nigeria-records-chloroquine-poisoning-after-trump-endorses-it-for-coronavirus-treatment.md",
      "title": "Nigeria records chloroquine poisoning after Trump endorses it for coronavirus treatment",
      "excerpt": "Health officials in Nigeria have issued a warning over chloroquine after they said three people in the country overdosed on the drug, in the wake of President Trump's comments about using it to treat coronavirus.",
      "heat": 122,
      "tags": null,
      "type": "article",
      "webUrl": "https://edition.cnn.com/2020/03/23/africa/chloroquine-trump-nigeria-intl/index.html",
      "ampWebUrl": "https://amp.cnn.com/cnn/2020/03/23/africa/chloroquine-trump-nigeria-intl/index.html",
      "cdnAmpWebUrl": "https://amp-cnn-com.cdn.ampproject.org/c/s/amp.cnn.com/cnn/2020/03/23/africa/chloroquine-trump-nigeria-intl/index.html",
      "publishedDateTime": "2020-03-23T01:41:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNN",
        "domain": "cnn.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnn.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cdn.cnn.com/cnnnext/dam/assets/200320115339-02-trump-presser-0320-super-tease.jpg",
          "width": 1100,
          "height": 619,
          "title": "Nigeria records chloroquine poisoning after Trump endorses it for coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-inside-the-race-for-a-vaccine-to-prevent-the-novel-coronavirus.md",
      "title": "Inside the race for a vaccine to prevent the novel coronavirus",
      "excerpt": "Experts say nationwide restrictions may need to be in place until there is a vaccine to thwart the novel coronavirus. When might that be?",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cbsnews.com/news/inside-the-race-for-a-vaccine-to-prevent-coronavirus-covid-19-60-minutes-2020-03-22/",
      "ampWebUrl": "https://www.cbsnews.com/amp/news/inside-the-race-for-a-vaccine-to-prevent-coronavirus-covid-19-60-minutes-2020-03-22/",
      "cdnAmpWebUrl": "https://www-cbsnews-com.cdn.ampproject.org/c/s/www.cbsnews.com/amp/news/inside-the-race-for-a-vaccine-to-prevent-coronavirus-covid-19-60-minutes-2020-03-22/",
      "publishedDateTime": "2020-03-22T19:49:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CBS News",
        "domain": "cbsnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cbsnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cbsnews1.cbsistatic.com/hub/i/r/2020/03/23/fb9837ec-2f5e-48e1-9458-535a43590b10/thumbnail/1200x630/6104c7bcb586b75021afe9d6350985c7/60-0322-vaccine50.jpg",
          "width": 1200,
          "height": 630,
          "title": "Inside the race for a vaccine to prevent the novel coronavirus",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-23-gilead-shifting-access-to-potential-coronavirus-drug-to-clinical-trials.md",
      "title": "Gilead shifting access to potential coronavirus drug to clinical trials",
      "excerpt": "Gilead Sciences Inc said on Sunday it was temporarily putting emergency access to its experimental coronavirus drug remdesivir on hold due to overwhelming demand and that it wanted most people receiving the drug to participate in a clinical trial to prove if it is safe and effective.",
      "heat": 145,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/health-coronavirus-gilead-sciences/gilead-shifting-access-to-potential-coronavirus-drug-to-clinical-trials-idUSL1N2BF0CJ",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSL1N2BF0CJ",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSL1N2BF0CJ",
      "publishedDateTime": "2020-03-22T17:06:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "Gilead shifting access to potential coronavirus drug to clinical trials",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    }
  ],
  "nextPage": null
}